Contact
Please use this form to send email to PR contact of this press release:
MyoKardia Begins Dosing in Phase 1 Clinical Study of MYK-224 for Hypertrophic Cardiomyopathy
TO:
Please use this form to send email to PR contact of this press release:
MyoKardia Begins Dosing in Phase 1 Clinical Study of MYK-224 for Hypertrophic Cardiomyopathy
TO: